169 related articles for article (PubMed ID: 38253629)
21. Study on the mechanism of Cortex Lycii on lung cancer based on network pharmacology combined with experimental validation.
Guo Z; Yin H; Wu T; Wu S; Liu L; Zhang L; He Y; Zhang R; Liu N
J Ethnopharmacol; 2022 Jul; 293():115280. PubMed ID: 35405252
[TBL] [Abstract][Full Text] [Related]
22. Network pharmacology integrated with experimental validation revealed potential molecular mechanisms of Camellia nitidissima C. W. Chi in the treatment of lung cancer.
Zhou A; Zhou C; Wang D; Qian M; Huang L
J Ethnopharmacol; 2023 Oct; 314():116576. PubMed ID: 37142145
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
Li YJ; Wang Y; Wang YY
J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
[TBL] [Abstract][Full Text] [Related]
24. Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation.
Bai C; Yang X; Zou K; He H; Wang J; Qin H; Yu X; Liu C; Zheng J; Cheng F; Chen J
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):573-84. PubMed ID: 26935715
[TBL] [Abstract][Full Text] [Related]
25. SRSF3 Restriction Eases Cervical Cancer Cell Viability and Metastasis via Adjusting PI3K/AKT/mTOR Signaling Pathway.
Zhang L; Li J; Zhang L
Contrast Media Mol Imaging; 2022; 2022():8497078. PubMed ID: 36237584
[TBL] [Abstract][Full Text] [Related]
26. Naringenin-Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling Pathways.
Lim W; Park S; Bazer FW; Song G
J Cell Biochem; 2017 May; 118(5):1118-1131. PubMed ID: 27606834
[TBL] [Abstract][Full Text] [Related]
27. [Mechanism of Marsdenia tenacissima against ovarian cancer based on network pharmacology and experimental verification].
Hu YJ; Wei LY; Zhao J; Zhu QF; Meng ZY; Meng JJ; Chen JJ; Xu LY; Zhou YY; Han YL
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(8):2222-2232. PubMed ID: 37282910
[TBL] [Abstract][Full Text] [Related]
28. BCL2L1 is identified as a target of naringenin in regulating ovarian cancer progression.
Xu J; Guo Z; Yuan S; Li H
Mol Cell Biochem; 2022 May; 477(5):1541-1553. PubMed ID: 35184257
[TBL] [Abstract][Full Text] [Related]
29. Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer.
Gao J; Yang S; Xie G; Pan J; Zhu F
Drug Des Devel Ther; 2022; 16():1947-1961. PubMed ID: 35757520
[TBL] [Abstract][Full Text] [Related]
30. Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota.
Lin C; Zeng Z; Lin Y; Wang P; Cao D; Xie K; Luo Y; Yang H; Yang J; Wang W; Luo L; Lin H; Chen H; Zhao Y; Shi Y; Gao Z; Liu H; Liu SL
Phytomedicine; 2022 Nov; 106():154401. PubMed ID: 36029647
[TBL] [Abstract][Full Text] [Related]
31. Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology.
Shao D; Liu X; Wu J; Zhang A; Bai Y; Zhao P; Li J
Phytomedicine; 2022 Jul; 102():154177. PubMed ID: 35636171
[TBL] [Abstract][Full Text] [Related]
32. Network pharmacology, molecular docking and experimental verification of the mechanism of huangqi-jixuecao herb pair in treatment of peritoneal fibrosis.
Dai H; Shan Y; Yu M; Wang F; Zhou Z; Sun J; Sheng L; Huang L; Sheng M
J Ethnopharmacol; 2024 Jan; 318(Pt A):116874. PubMed ID: 37437794
[TBL] [Abstract][Full Text] [Related]
33. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
[TBL] [Abstract][Full Text] [Related]
34. Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer.
Wang Z; Cui Q; Shi L; Zhang M; Song P; Duan D; Guo W
Recent Pat Anticancer Drug Discov; 2022; 17(3):297-311. PubMed ID: 34951580
[TBL] [Abstract][Full Text] [Related]
35. Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway.
Bai X; Ma Y; Zhang G
Oncol Rep; 2015 Jun; 33(6):3085-92. PubMed ID: 25962638
[TBL] [Abstract][Full Text] [Related]
36. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
Teng P; Jiao Y; Hao M; Tang X
J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322
[TBL] [Abstract][Full Text] [Related]
37. Prediction of the potential mechanism of compound gingerol against liver cancer based on network pharmacology and experimental verification.
Su M; Wang X; Cao G; Sun L; Ho RJY; Han Y; Hong Y; Wu D
J Pharm Pharmacol; 2022 Jun; 74(6):869-886. PubMed ID: 35429380
[TBL] [Abstract][Full Text] [Related]
38. Study on the mechanism of action of Saposhnikovia divaricata and its key phytochemical on rheumatoid arthritis based on network pharmacology and bioinformatics.
Jiang Y; Zhong S; Tan H; Fu Y; Lai J; Liu L; Weng J; Chen H; He S
J Ethnopharmacol; 2024 Mar; 322():117586. PubMed ID: 38104871
[TBL] [Abstract][Full Text] [Related]
39. Naringenin-induced migration of embrynoic trophectoderm cells is mediated via PI3K/AKT and ERK1/2 MAPK signaling cascades.
Lim W; Song G
Mol Cell Endocrinol; 2016 Jun; 428():28-37. PubMed ID: 26994515
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the mechanism of Isobavachalcone in treating rheumatoid arthritis through a combination strategy of network pharmacology and experimental verification.
Wang S; Du Q; Sun J; Geng S; Zhang Y
J Ethnopharmacol; 2022 Aug; 294():115342. PubMed ID: 35525528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
